MYO18A and Alzheimer disease: Increased TGF-β1 levels were also observed in AD patients [54], where aberrant TGF-β signaling was found to induce self-aggregation of TGF-β1-induced antiapoptotic factor (TIAF1), causing formation of Aβ plaques in AD [55].